Previous 10 | Next 10 |
BOONTON, N.J. , June 2, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that the company is pa...
DALLAS , May 14, 2020 /PRNewswire/ -- Corporate Highlights Core specialty finance segment generated an 11.3% adjusted ROIC, and yielding assets increased to $179.2 million , a 15.7% increase in comparison to the quarter ended March 31, 2019 Rajiv Khosla , Ph.D. appointed as C...
BOONTON, N.J. , May 4, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring o...
SWK Holdings Corporation (SWKH) Q4 2019 Earnings Conference Call March 31, 2020 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors, Inc. Winston Black - Chairman and Chief Executive Officer Conference Call Participants Presentation Operator Goo...
DALLAS , March 30, 2020 /PRNewswire/ -- Corporate Highlights Core specialty finance segment generated a 12.6% adjusted ROIC and yielding assets increased 4.8% year over year to $175.1 million Closed Enteris Biopharma acquisition SWK Holdings common stock uplisted to Nasdaq C...
DALLAS , March 26, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today announced its preliminary revenue and non-GAAP adjusted net income for the fourth quart...
DALLAS , Feb. 28, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its partner companies during the...
BOONTON, N.J. , Feb. 10, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring...
BOONTON, N.J. , Jan. 27, 2020 /PRNewswire/ -- Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that it has rece...
DALLAS , Jan. 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbo...
News, Short Squeeze, Breakout and More Instantly...
SWK Holdings Corporation Company Name:
SWKH Stock Symbol:
OTCMKTS Market:
SWK Holdings Corporation Website:
Company Also Promotes Controller DALLAS, TX / ACCESSWIRE / July 8, 2024 / SWK Holdings Corporation (Nasdaq:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, is pleased to announce the appointment of ...
2024-06-24 21:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate Highlights First quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023 First quarter 2024 finance r...